Prioritizing lean proteins, healthy fats, and low-fiber foods during the first 34 weeks gives your digestive system less challenging material to process while adapting
Tirzepatide is a groundbreaking medication that combines the effects of GLP-1 and GIP receptor agonism to reduce appetite, improve blood sugar control, and promote significant weight loss
It's crucial to highlight that these peptides should not be used during pregnancy or breastfeeding due to a lack of human research and preclinical studies suggesting teratogenic potential
This can enhance patient adherence and satisfaction with the treatment
NICE guidance recommends GLP-1 receptor agonists for type 2 diabetes when triple therapy is insufficient and specific BMI criteria are met, or for weight management in adults with BMI 30 kg/m (or 27 kg/m with comorbidities) through specialist services
Ginger supplements or peppermint tea offer natural alternatives for mild symptoms